Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CT

Weizhi Xu, Jiayu Cai, Tianxing Peng, Tinghua Meng, Yizhen Pang, Long Sun, Hua Wu, Jingjing […]

2023-12-06T17:15:15+00:00October 20th, 2023|Publications|

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

2023-10-11T13:12:33+00:00October 11th, 2023|News|

Focus on FAPI Newsletter – Summer 2023

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI community,

It was a busy and exciting summer.

In […]

2023-09-07T19:51:11+00:00August 29th, 2023|Newsletter|

Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [18F]FAPI-74 with [18F]FDG in Patients with PDAC: A Prospective Exploratory Study

Emil Novruzov1, Frederik L Giesel1,2, Yuriko Mori1, Peter L Choyke3, Mardjan Dabir1, Eduards Mamlins1, Dominik […]

2023-08-29T18:12:28+00:00August 29th, 2023|Publications|

Comparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib

Meiqi Wu1, Yanyu Wang2, Qiao Yang1, Xuezhu Wang1, Xu Yang2, Haiqun Xing1, Xinting Sang2, Xiang […]

2023-08-29T18:05:17+00:00August 29th, 2023|Publications|

Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis

Alessio Rizzo1, Manuela Racca1, Federico Garrou2, Elisabetta Fenocchio3, Luca Pellegrino4, Domenico Albano5, Francesco Dondi5, Francesco […]

2023-08-29T18:15:27+00:00August 29th, 2023|Publications|

FAP symposium another success at 2023 SNMMI meeting

June 25, 2023 – For the second year in a row, the spotlight shone on […]

2023-12-20T12:42:14+00:00July 7th, 2023|News|

RLS and SOFIE Enter Strategic Partnership for Distribution of Nuclear Medicine Doses for Patients

LAKE ZURICH, Il. and DULLES, Va. — June 21, 2023, RLS (USA), […]

2023-06-21T19:09:58+00:00June 21st, 2023|News|

Focus on FAPI Newsletter – Spring 2023

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI community,

This quarter, the FAPI team celebrated […]

2023-06-12T22:46:31+00:00June 12th, 2023|Newsletter|

SOFIE partners with BAMF Health, diversifying sites for Phase II [68Ga]FAPI-46 study

SOFIE has added BAMF Health, a novel cancer treatment center in Grand Rapids, Michigan, as […]

2023-06-06T23:49:02+00:00June 6th, 2023|News|
Go to Top